CORRECTION – Rigrodsky & Long, P.A. Files Class Action Suit Against Aratana Therapeutics, Inc.
06 juin 2019 18h27 HE
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., June 06, 2019 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Rigrodsky & Long, P.A., please note the date in the fifth paragraph should be...
PETX, KEYW, and ZAYO SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers
09 mai 2019 14h22 HE
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., May 09, 2019 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: Aratana Therapeutics, Inc. (NASDAQ GM: PETX) regarding possible breaches of...
PETX, WP, and EFII SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts
30 avr. 2019 14h17 HE
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., April 30, 2019 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: Aratana Therapeutics, Inc. (NASDAQ GM: PETX) regarding possible breaches of...
ARATANA THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Merger
26 avr. 2019 20h25 HE
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., April 26, 2019 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A.: Do you own shares of Aratana Therapeutics, Inc. (NasdaqGM: PETX)? Did you purchase any of your shares prior to...
PETX ALERT: Rosen Law Firm Reminds Aratana Therapeutics, Inc. Investors of Important Deadline in Class Action – PETX
17 mars 2017 16h57 HE
|
The Rosen Law Firm PA
NEW YORK, March 17, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Aratana Therapeutics, Inc securities (NASDAQ:PETX) from March 16, 2015 through...
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Aratana Therapeutics, Inc. – PETX
02 mars 2017 18h15 HE
|
The Rosen Law Firm PA
NEW YORK, March 02, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Aratana Therapeutics, Inc....